# Intra-Arterial Tirofiban After Complete Recanalization for Acute Intracranial Large-Vessel Occlusion

Study · id `cardio:ct-nct07537933` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07537933](<https://clinicaltrials.gov/study/NCT07537933>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07537933

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 344 participants.

## Technical summary

Registry record NCT07537933. Randomized; single masking; primary purpose treatment. Start 2026-04 (anticipated); primary completion 2028-04 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 344 participants (planned count; ClinicalTrials.gov record NCT07537933, source copy `cardio:ctgov-nct07537933-2026-04-22`, retrieved 2026-10-26)
- Planned start: 2026-04 (anticipated) (ClinicalTrials.gov record NCT07537933, source copy `cardio:ctgov-nct07537933-2026-04-22`, retrieved 2026-10-26)
- Primary completion: 2028-04 (anticipated) (ClinicalTrials.gov record NCT07537933, source copy `cardio:ctgov-nct07537933-2026-04-22`, retrieved 2026-10-26)
- Completion: 2028-04 (anticipated) (ClinicalTrials.gov record NCT07537933, source copy `cardio:ctgov-nct07537933-2026-04-22`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07537933, source copy `cardio:ctgov-nct07537933-2026-04-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07537933-2026-04-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Intra-Arterial Tirofiban After Complete Recanalization for Acute Intracranial Large-Vessel Occlusion
- Acronym: IA-Tirofiban
- Condition: Acute Ischemic Stroke
- Condition: Large-vessel Occlusion
- Condition: Endovascular Treatment
- Intervention (Drug): Tirofiban
- Lead sponsor: Shandong Provincial Hospital
- Lead sponsor class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Shandong Provincial Hospital (`cardio:org-shandong-provincial-hospital`)

## Provenance

Content hash: 0a41eef4005e902ee32b9a36e60c51ffb5d637e8616b394391ba920308aa7e87
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
